UK markets closed

Hikma Pharmaceuticals PLC (HKMPY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
47.130.00 (0.00%)
At close: 10:11AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,875,000
2,875,000
2,517,000
2,553,000
2,341,000
Cost of revenue
1,485,000
1,485,000
1,279,000
1,252,000
1,140,000
Gross profit
1,390,000
1,390,000
1,238,000
1,301,000
1,201,000
Operating expenses
Research development
149,000
149,000
144,000
143,000
137,000
Selling general and administrative
544,000
544,000
509,000
488,000
464,000
Total operating expenses
785,000
785,000
756,000
704,000
641,000
Operating income or loss
605,000
605,000
482,000
597,000
560,000
Interest expense
90,000
90,000
77,000
56,000
56,000
Income before tax
281,000
281,000
233,000
544,000
558,000
Income tax expense
89,000
89,000
42,000
124,000
128,000
Income from continuing operations
192,000
192,000
191,000
420,000
430,000
Net income
190,000
190,000
188,000
421,000
431,000
Net income available to common shareholders
190,000
190,000
188,000
421,000
431,000
Basic EPS
1.34
1.72
1.68
3.65
3.65
Diluted EPS
1.33
1.70
1.68
3.61
3.62
Basic average shares
110,500
110,431
111,864
115,500
118,000
Diluted average shares
111,000
111,184
112,454
116,500
119,000